Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:56 AM
Study NCT ID:
NCT00769418
Status:
COMPLETED
Last Update Posted:
2015-08-19
First Post:
2008-10-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2004-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-06
First Submit QC Date:
None
Study First Post Date:
2008-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-18
Last Update Post Date:
2015-08-19
Last Update Post Date Type:
ESTIMATED